NewsRx

Search our medical news database

HIV Vaccines

Clinical Trials of Immunization Against Clade A HIV-1 Virus Begin

Published in AIDS Weekly, September 18th, 2000

Researchers began clinical trials August 31, 2000, with a vaccine targeted at an African strain of AIDS.

The vaccine is the first specifically designed to combat the Clade A HIV-1 virus, the most prevalent strain in many parts of Africa.

Eighteen people volunteered to receive injections of the vaccine at Churchill Hospital in Oxford, England. If the tests are successful, trials will begin in Nairobi, Kenya, within six months, according to the Medical Research Council, a U.K. government-funded national research organization.

The hope is that the vaccine will stimulate the body to produce killer T cells that will destroy HIV...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook